LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation

Genes Chromosomes and Cancer

Volumn 48, Issue 12, 2009, Pages 1027-1036

  Dai, Hai Ping ^a   Xue, Yong Quan ^a,b   Zhou, Jian Wei ^b   Li, Ai Ping ^b   Wu, Ya Fang ^a   Pan, Jin Lan ^a   Yong, Wang ^a   Jun, Zhang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PAXILLIN; PROTEIN LPXN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL STRAIN 3T3; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FUSION GENE; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANIMALS; BONE MARROW CELLS; CELL ADHESION MOLECULES; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TRANSLOCATION, GENETIC;

MUS MUSCULUS;

EID: 70350220616     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20704     Document Type: Article

References (30)

1. Adya N, Stacy T, Speck NA, Liu PP. 1998. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol Cell Biol 18:7432-7443.
2. Asou N, Yanagida M, Huang L. 2007. Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia. Blood 109:4023-4027. (Pubitemid 46641757)
3. Chan EM, Comer EM, Brown FC, Richkind KE, Holmes ML, Chong BH, Shiffman R, Zhang DE, Slovak ML, Willman CL, Noguchi CT, Li Y, Heiber DJ, Kwan L, Chan RJ, Vance GH, Ramsey HC, Hromas RA. 2005. AML1-FOG2 fusion protein in myelodysplasia. Blood 105:4523-4525.
4. Chew V, Lam KP. 2007. Leupaxin negatively regulates B cell receptor signaling. J Biol Chem 282:27181-27191. (Pubitemid 47501973)
5. Chinen Y, Taki T, Nishida K, Shimizu D, Okuda T, Yoshida N, Kobayashi C, Koike K, Tsuchida M, Hayashi Y, Taniwaki M. 2008. Identification of the novel AML1fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA. Oncogene 27:2249-2256.
6. Dai H, Xue Y, Pan J, Wu Y, Wang Y, Shen J. 2007. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia. Cancer Genet Cytogenet 2:120-124.
7. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M. 1998. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood 91:4028-4037. (Pubitemid 28261962)
8. Gao J, Erickson P, Gardiner K, LeBeau MM, Diaz MO, Patterson D, Rowley JD, Drabkin HA. 1991. Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogeneous leukemia. Proc Natl Acad Sci USA 88:4882-4886. (Pubitemid 21914647)
9. Hromas R, Busse T, Carroll A, Mack D, Shopnick R, Zhang DE, Nakshatri H, Richkind K. 2001. Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein. Blood 97:2168-2170. (Pubitemid 32239101)
10. Imagama S, Abe A, Suzuki M, Hayakawa F, Katsumi A, Emi N, Kiyoi H, Naoe T. 2007. LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). Eur J Haematol 79:25-31. (Pubitemid 47000610)
11. Lipsky BP, Beals CR, Staunton DE. 1998. Leupaxin is a novel LIM domain protein that forms a complex with PYK2. J Biol Chem 273:11709-11713.
12. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. 1998. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18:7176-7184.
13. Meyers S, Lenny N, Hiebert SW. 1995. The t(8:21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 15:1974-1982.
14. Mikhail FM, Coignet L, Hatem N, Mourad ZI, Farawela HM, Kaffash DMEl, Farahat N, Nucifora G. 2004. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 39:110-118.
15. Mitleman F, Johansson B, Mertens F. 2009. Mitleman database of chromosome aberrations in cancer [Internet]. Updated May. Available at: http://cgap.nci.nih.gov/Chromosomes/ Recurrent Aberrations.
16. Morrow M, Samanta A, Kioussis D, Brady HJ, Williams O. 2007. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and dimerization and corepressor binding domains of TEL. Oncogene 26:4404-4414. (Pubitemid 47014465)
17. Nguyen TT, Ma LN, Slovak ML, Bangs CD, Cherry AM, Arber DA. 2006. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDF2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer 45:918-932.
18. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD. 1994. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21) (q26;q22) translocations. Proc Natl Acad Sci USA 9:4004-4008.
19. Osato M. 2004. Point mutations in the RUNX1/AML1 gene: Another actor in RUNX1 leukemia. Oncogene 23:4284-4296. (Pubitemid 38765137)
20. Paulsson K, Békássy AN, Olofsson T, Mitelman F, Johansson B, Panagopoulos I. 2006. A novel and cytogenetieally cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia 20:224-249. (Pubitemid 43148659)
21. Qiu J, Wong J, Tweardy DJ. 2006. Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta. Oncogene 25:3982-3993. (Pubitemid 43990754)
22. Ramsey H, Zhang DE, Richkind K, Burcoglu-O'Ral A, Hromas R. 2003. Fusion of AML1/RUNX1 to Copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t (12;21) translocation. Leukemia 17:1665-1666.
23. Ramsey H, Christopherson K, Hromas R. 2004. Forced expression of AML1-AMP19, a fusion transcript generated from a radiation- associated t(19;21) leukemia, blocks myeloid differentiation. Leuk Res 28:863-868. (Pubitemid 38760048)
24. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N, Pollán M, Sanchez-Aguilera A, Menarguez J, Campo E, Martinez P, Mateo M, Piris MA. 2005. Splenic marginal zone lymphoma: Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 106:1831-1838. (Pubitemid 41208601)
25. Sahu SN, Nunez S, Bai G, Gupta A. 2007. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. Am J Physiol Cell Physiol 292:C2288-C2296. (Pubitemid 47080534)
26. Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M. 2005. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 44:265-270.
27. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR. 2000. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738-743.
28. Tang L, Guo B, Javed A, Choi JY, Hiebert S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Zhou GW. 1999. Crystal structure of the nuclear matrix targeting signal of the transcription factor AML-1/PEBP2αB/CBFa2. J Biol Chem 274:33580-33586.
29. Wang Q, Stacy T, Binder M. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93:3444-3449.
30. Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Dyke DLV, Wiktor A, Rowley JD. 2004. PRDX4, a member of the peroxiredoxin family, is fused to AM L1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chromosomes Cancer 40:365-370.